00:00
00:00
00:00
Scancell Holdings - SCIB1 Phase 1/2 clinical trial results presented at ASCO and DNA ImmunoBody patent granted in United States

Dr Richard Goodfellow, Joint Chief Executive Officer dicusses the recent SCIB1 Phase 1/2 clinical trial results presented at ASCO and patent DNA ImmunoBody patent granted in United States.

Dr Richard Goodfellow
Joint Chief Executive Officer

Company Events - SCANCELL HOLDINGS